结核病患者白细胞减少原因探讨及治疗观察  

Study on cause treatment of leukocyte reduction tuberculosis cases

作　　者：苏海飞[1] 张武[1] 陈悦文[1] 周锡润[1] 

机构地区：[1]高州市人民医院感染内科,525200

出　　处：《国际医药卫生导报》2009年第18期44-45,共2页International Medicine and Health Guidance News

摘　　要：目的分析结核病患者白细胞减少的原因，探讨防治措施。方法观察肺结核患者抗结核治疗前后血液白细胞总数变化，对其中104例出现血液白细胞减低患者抗结核治疗以前用药情况、造血功能、免疫功能及抗结核药物治疗因素等进行分析，根据不同病因给予相应治疗。结果104例白细胞减少患者中因结核感染所致11例，占10．6％；抗结核治疗前及治疗过程中应用非抗结核性药物25例，占24．0％，其中头孢类抗生素为主；抗结核药物（包括喹诺酮类）44例，占42．3％；免疫功能异常12例，占11．5％；其他如放射检查治疗10例，占9．6％。结论结核病患者白细胞减少原因不同，给予相应措施预防及治疗可取得满意结果。Objective To analyze causes of leukocyte among pulmonary tuberculosis cases, and to explore the treatment measures. Methods Observe the change of amount of the White Blood Cell before and after anti-tuberculosis treatment in puhnonary tuberculosis patients analyze the pre-tuberculosis treatment,hematopoiesis, immunology,and anti-tuberculosis medication of 104 patients who had leukocyte give treatment in accordance with different etiology. Results Of the 104 patients, tuberculous 11 patients, caused 10.6%; non-tuberculosis anti- biotics（ mainly cephalothin ） 25 patients, caused 24.0%; dysfunction of immunology 12 patients, caused 11.5%; anti-tuberculosis drugs（ including quinolone ） 44 patients , caused 42.3%; radiation examination and treatment caused 9.6%. Conclusion Leukocyte among pulmonary tuberculosis cases has different etiology,which should be managed accordingly.

关 键 词：结核 白细胞减少 原因 治疗 

分 类 号：R5[医药卫生—内科学]